INTRODUCTION
The purpose of this study was to gain insight into the mechanism by which certain toxic gases produce chemical injury to the lungs when inhaled. The mechanisms responsible for producing lung edema after exposure to phosgene (CG), bis(trifluoromethyl)disulfide (TFD), or perfluoroisobutylene (PFIB) remain unknown. Some of the pulmonary responses to acute lung injury include complement activation, aggregation of granulocytes and platelets, stimulation of arachidonic acid metabolism and generation of toxic oxygen species [Said, 1985] . Selected lung peptides also may play a. role in either pathologic or protective mechanisms involved in acute lung injury [ Dey and Said, 1985] . The current scientific and medical literature indicates that these responses are often overlapping, and the generation of toxic oxygen species may be a common molecular action in each case. Toxic oxygen species include superoxide anion (02 " ), hydrogen peroxide (H 2 0 2 ), hydroxyl radical (OH), singlet oxygen (102) and peroxide radical (ROO, where R = lipid). There is mounting evidence suggesting that the reduction of molecular oxygen to any of these moieties results in damage to biologic membranes, and can be generated by pulmonary epithelia and endothelia, macrophages and neutrophils. The tissue damage is characterized by lipid peroxidation, nucleic acid damage, carbohydrate depolymerization, and protein denaturation [Taylor, 1985] . These reactive oxygen metabolites are generated by specific enzymes (e.g., xanthine oxidase), by autoxidation and by energy transfer reactions, all normal processes in aerobic metabolism. Similarly, there are normal antioxidant defenses that prevent cellular toxicity and are characterized as enzymatic (e.g., superoxide dismutase, catalase, glutathione peroxidase) or non-enzymatic (e.g., vitamins E and C, glutathione, cysteine and other thiols). When oxidant production overcomes the endogenous defense system, tissue damage ensues. A logical approach to determining if lung damage is related to toxic oxygen species is to manipulate the enzymatic/non-enzymatic control over the balance of these oxygen radical forces. Indeed, the pathogenesis of pulmonary edema has been attenuated by enzymes that promote the removal of toxic oxygen moieties [Milligan, 1988] and by leukopenia inducers [Shasby, 1982] .
Although toxic oxygen species generation is suggested as a likely mechanism of pulmonary injury in the aforementioned studies, it is not known if this is a mechanism for the injury observed after inhalation exposure to CG, TFD or PFIB. In this study, rats were administered intervention compounds based largely on the above biochemical schema.
I1

MATERIALS AND METHODS
Experimental Paradigm. Male Sprague-Dawley rats (140-325 g) were assigned to one of four test groups: Group A, 6 rats treated with the selected drug and exposed to the selected toxic gas; Group B, 6 rats treated with the drug vehicle and exposed to the gas; Group C, 2 rats treated with the chosen drug and exposed to air; and Group D, 2 rats treated with drug vehicle and exposed to air. For statistical analysis, the results from groups C and D (for each drug respectively) were pooled. The drug or vehicle was administered either 15 to 30 minutes before or 15 to 30 minutes after exposure to the gas, with thee exception of hydroxyurea. Hydroxyurea was given twice daily for three da3a prior to exposure, and blood leukocyte counts were determined to insure that leukopenis had been attained (Orthodiagnostics ELT 8/DS Lazer Hematology Analyzer, Westwood, MA). Ten-minute exposures to the gases were conducted. In the initial experiments, ite animals were observed for 24 hours after exposure. It was decided later to shorten the post-exposure period to 5 hours, usually using a higher concentration of the toxic gas to obtain pulmonary edema within the shortened observation period. In determining whether or not an adequate exposure to the toxic gas had been obtained, we arbitrarily categorized each experiment as comprising an "adequate exposure" when the lung weight to body weight ratio of the vehicle-treated, gas-exposed rats (group B) was found to be at least twice that of the vehicle-treated air-exposed rats (group D).
Drugs administered. Drugs were N-acetylcysteine 200 mg/kg (Bristol-Myers Co., Evansville, IN) (vehicle, 0.9 % saline), pentigetide 2 mg/kg (Immunetech Pharmaceuticals, San Diego, CA) (vehicle, phosphate buffered saline), ibuprofen 50 mg/kg (Upjohn Co., Kalmazoo, MI) (vehicle, Placebo for Ibuprofen Sterile Solution, 50 mg/ml, Study Lot #40,524, Upjohn Corp.), lodoxamide tromethamine 10 mg/kg (Upjohn Co., Kalmazoo, MI) (vehicle, 0.9% saline), hydroxyurea 1500 mg/kg (Sigma Chemical Co., St. Louis, MO) (vehicle, 0.9% saline) and three experimental Upjohn lazaroid compounds, U78517F (vehicle, distilled water) U75412E (vehicle, 0.05N saline), and U74006F (vehicle, 0.9%saline). The latter three compounds were all given at 10 mg/kg. All drugs were given as a single dose, except hydroxyurea, which was given daily for three days. The drug or its vehicle was administered intraperitoneally (ip), with the exception of hydroxyurea. Hydroxyurea was given ip to the phosgene-exposed rats, and by gavage to the rats exposed to TFD and PFIB.
Inhalation erposure apparatus. Each rat was exposed to the toxic gas or air for 10 minutes through his nose and mouth. The generation and maintenance of appropriate concentrations of the required gases have been described previously (Keeler et al., 1990) . A head-stock type of restraint (Process Instruments Corp., Brooklyn, NY) was used to hold the rats in fixed position in the gas manifold.
Toxic Compounds Studied. Gases were administered in concentrations that would produce pulmonary edema within the observation period and were continuously monitored during exposure by an infra-red spectrometer (Miran 1A, Foxboro Co., Necropsy and Disposition of Tissue Samples. Rats that died prior to the 5-or 24-hour endpoints were necropsied at time of death. Survivors were sacrificed by guillotine at the 5-or 24-hour endpoint after exposure and necropsied. The lungs were removed and trimmed free of adjacent tissues, then blotted and weighed. The right caudal lobe was then excised, weighed, and dried to a constant weight at 1000 C. The right cranial lobe was immersion fixed in Zenker's fixative. The left lung was inflated with and then immersion fixed in 10% formalin. The heart, thymus and a mesenteric lymph node, as well as portions of the trachea, spleen, and left kidney, were also preserved in formalin.
Histopathology. Representative sections of the lungs were reviewed by pathologists and graded on a scale of 1 to 4. No blinding procedures were utilized in the scoring. Criteria were as follows: 0 = normal; 1 = minimal lesion (widened lymphatic and perivascular spaces, slight increase in perivascular and/or alveolar macrophages and/or eosinophils, occasional amounts or wisps of eosinophilic edema fluid in alveoli); 2 = mild lesion (multifocally, <20% of alveoli contain traces of eosinophilic edema fluid and increased number of alveolar macrophages perivascular spaces are widened and interstitial inflammatory cells are slightly increased); 3 = moderate lesion (20-50% of alveoli contain eosinophilic edema fluid , scattered alveoli have strands of fibrin within alveoli or perivascularly, septae are thickened and inflammatory cells within alveoli and interstitium are increased); 4 = severe lesion (diffuse alveolar edema, <50% of alveoli are involved, widespread fibrin deposition, marked thickening of alveolar septa, increase alveolar and interstitial inflammatory cells).
Statistical Analysis. Two primary indices of the severity of lung edema were analyzed by 2-tailed one way analysis of variance, (1) the lung weight to body weight ratio (x 100), and (2) the right caudal lobe wet weight to dry weight ratio. If a significant difference between the means was found, at a probability level of p < 0.05, a comparison between groups was performed using Newnan-Keuls Analysis. Two additional parameters were tested in some of the experiments: (1) the proportions of the treated and the untreated rats that died within the 24-hour post-exposure period were compared using Fisher's Exact Test; and (2) the lung injury scores generated by histopathology examination were compared between the treated and untreated toxic gas-exposed rats and analyzed using the Mann-Whitney U Test. No formal analysis of the data for normality of distribution was made.
RFSULTS
Results are shown in the bar graphs of Figures 1 through 45 , and statistically significant results for the lung weight ratios are described in the narrative summary which follows. In the intergroup comparisons, the presence of a significant difference at the p <0.05 level is indicated as follows:
* indicates a significant difference between group B, the gas-exposed vehicletreated group, and group A, the gas-exposed drug -treated group.
+ indicates a significant difference between group B, the gas-exposed vehicletreated group, and group C, the air-exposed drug -treated group.
+ indicates a significant difference between group B, the gas-exposed vehicletreated group, and group D, the air-exposed vehicle -treated group. No significant differences were found between groups C and D in these experiments, and no symbols are shown for those comparisons. To avoid complexity, comparisons of groups A and C and of groups A and D are not presented. Therefore only comparisons between group B and the A, C, and D groups are noted here. An absence of any symbol over group B indicates that comparison of group B with groups A and C was made and found to be not significant.
Results by drug and gas studied. an adequate exposure. When repeated at a higher dose of PFB, a significant reduction in the WW/DW ratio was found. The LW/BW ratio trended similarly but did nc reach statistical significance.
(2) PENTIGETIDE Pre-treatment:
On an initial experiment, significant reductions in LW/BW and WW/DW ratios were found. On repetition at a higher phosgene concentration and a shorter observation period, this was not confirmed. b. vs. TFD exposure, Figure 5 . A significant increase in LW/BW ratio was noted, but the WW/DW ratio was not significantly increased.
c. vs. PFIB exposure, Figures 6a & 6b.
On an initial experiment, an adequate exposure was nat obtained. When the experiment was repeated at the same PFIB concentration, adequate exposure was obtained but no significant differences in treatment and vehicle groups was found. and 15b) , an adequate exposure was not obtained. On a third experiment at a greater PFIB concentration, a significant decrease in the WW/DW ratio was found, but the decrease in LW/BW ratio was not significant. On a fourth repetition at a slightly lower PFIB concentration, no significant differences between the gas-exposed groups were noted, but a similar trend was noted.
(6) U78517F Pre-treatment: a. vs. CG exposure, Figure 16 . b. vs. TFD exposure, Figure 17 . A significant reduction was found in the LW/BW ratio, but the WW/DW ratio was not significantly reduced. c. vs. PFIB exposure, Figure 18 . Significant reductions were found in both LW/BW and WW/DW ratios. On an initial experiment an adequate exposure was not obtained. When the experiment was repeated at the same concentration, a significant increase in the LW/BW ratio was found in the drug-treated, gas-exposed group, but this was not accompanied by a significant difference in the WW/DW ratio. When the experiment was repeated again, at a higher concentration, a significant decrease in the LW/BW ratio was found in the drug-treated, gas-exposed group. The WW/DW ratio trended in the same direction but did not reach statistical significance. c. vs. PFIB exposure, Figure 21 . On an initial experiment, an adequate exposure was not obtained. When the experiment was repeated at higher PFIB concentration, a reduction in the LW/BW index was found. The change in the WW/DW index was minimal. When the experiment was repeated at an even higher concentration of PFIB, no significant differences were found between drug and vehicle-treated groups. An initial experiment failed to achieve an adequate exposure. On repetition at the same PFIB concentration, no significant differences were noted between gas-exposed groups. exposure was not obtained. When the experiment was repeated at a higher concentration, no significant differences were found between the gas-exposed groups. On an initial experiment a significant increase in lung weights was not produced by the gas exposures. When the experiment was repeated at a higher gas concentration, no significant differences in the ratios for treated and untreated rats were found. c. vs. PFIB exposure, Figure 45 . The microscopic studies of the lung sections were scored for severity of lung damage, as described in materials and methods section, and the scores are shown in Table 3 . Where the scores are absent no pathology studies were performed. Each pair of figures represents the average pathology score in the drug treated group followed by colon, followed by the pathology score in vehicle treated group.
11) IBUPROFEN
12) LODOXAMIDE
* indicates 24-hour observation periods. Absence of an asterisk indicates five hour observation periods. + significant at the p -0.05 level by Mann-Whitmey test. Gas concentraions are indicated in parentheses (mg/rn).
DISCUSSION
The purpose of these studies was to evaluate the possibility that generation of toxic oxygen species is a molecular mechanism by which inhalation of PFIB, TFD and CG causes pulmonary edema. The drugs chosen for study in these experiments are believed to interfere, directly or indirectly, with generation of toxic oxygen species or aid in the disposition of toxic radicals. N-acetylcysteine is thought to contribute to intracellular replenishment of glutathione, which subsequently acts as a sacrificial oxidant to conjugate active oxygen species (Moldeus et al., 1986) . Pentigetide is thought to moderate immune inflammatory reactions (Hamburger, 1975) with their associated inflammatory oxygen radical production. It has also been reported to inhibit histamine release (Plummer et al., 1989 ) from calcium ionophore triggered mast cells. Ibuprofen, in addition to its cyclooxygenase inhibitory effects in preventing prostaglandin production (Vane, 1971) , is thought to chelate iron, thus interfering with iron-mediated hydroxyl radical generation (Kennedy et al., 1990) . lbuprofen is also thought to act through hydroxyl radical scavenging (Aruoma and Halliwell, 1988) . Further, ibuprofen has been shown to attenuate the production of hypochlorous acid from the reaction of halides with the hydrogen peroxide produced in respiratory bursts of neutrophils (Carey et al., 1990) . Lodoxamide is an inhibitor of rat lung xanthine oxidase (White, 1981) . Xanthine oxidase catalyzes the production of uric acid from xanthine, generating superoxide radicals and hydrogen peroxide. These in turn combine to form highly active hydroxyl radicals through the metal catalyzed Haber-Weiss reaction. Hydroxyurea produces leukopenia. When activated, leukocytes produce toxic oxygen radicals as part of their defense against foreign organisms. Hydroxyurea is thought to interfere with an enzyme, ribonucleoside diphosphate, which is utilized in the production of deoxyribonucleic acid (DNA) (Goodman et al., 1980) . DNA in turn is essential in the replication of leukocytes. Interference with the enzyme leads to leukopenia, reducing the potential for toxic oxygen radical production.
The manner in which lazaroid drugs protect against oxidative stress is not clearly known. One suggested method (Braughler et al., 1987) is by chelating iron, thus reducing the amount of oxygen radicals produced by iron catalyzed Fenton reactions. Other suggested mechanisms include scavenging lipid hydroperoxides and superoxide radicals (Hall et al., 1988) . These studies were conducted over a two-year period, during which time improvements were made in techniques and procedures. Shortening the post-exposure observation periods allowed completion of experiments in a day. Analysis of the results indicates this did not result in failure to observe significant edema at necropsy. This may be concluded from the fact that the proportion of short observation period experiments in which significant lung weight increases resulted from the gas exposures was greater than the proportion (57%) observed in the experiments using the longer observation periods. Likewise, the ability of the procedures to permit detection of differences in the drug-treated as opposed to the vehicle-treated gas-exposed groups did not appear to be less in the short as opposed to the long observation period procedures. The proportion of experiments in which significant differences were noted between drug and vehicletreated, gas-exposed groups was equal (26%) in the short and long observation period groups. The possibility that results may be different using the two observation periods cannot be excluded, but seems unlikely.
Difficulty in maintaining appropriate gas concentrations at the nose and mouth of the rats may have contributed to the variation in lung weight ratios found. Additional variation in these ratios may gave resulted from accumulation of blood in the tracheobronchial tree after euthanasia.
In deciding that a given drug reduced the development of the lung edema from exposure to a toxic gas, we relied primarily on two indices of increased lung weight, namely lung to body weight (LW/BW) ratio and wet to dry caudal lobe weight (WW/DW) ratio (for convenience, we present the lung to body weight ratios multiplied by 100). Both indices reflect the degree of lung edema, but each is subject to different experimental and recording errors. We have used them as cross-checks on each other. In all but two instances, the indices trend in the same direction, but statistical significance was often present for one index, and absent in the corresponding paired index. An increase in the lung to body weight ratio reflects pulmonary edema as long as there is no concomitant body weight loss (Currie et al., 1987) . With the exception of the experiments involving hydroxyurea, there were no differences in average body weight between groups A and B. Therefore, in these experiments, the differences in LW/BW ratios should reflect differences in the amount of lung edema. The lung weight to dry weight ratio is considered a good index of pulmonary edema if marked edema is present. In lesser degrees of edema, the proportional increases in wet weight (due to water) and dry weight (due to protein leakage) may be comparable (Currie et al., 1985) .
In a large series of experiments such as these (71 experiments), when statistical analysis is made at a double tailed probability level of p <.05, approximately two (.025 x 71) positive results might be expected if none of the drugs had a beneficial effect in reducing the amount of lung edema produced. In these experiments, however, significantly less weight gain in the drug-treated group was noted in 20 experiments (a greater weight gain in the drug-treated group was noted in four experiments). In the absence of a preventive effect of any drug studied, this proportion would be expected to occur in less than 1 out of 1000 series of such experiments. Therefore, the results of the experiments reported here clearly reflect a reduction in lung edema due to some of the drugs studied, even though occasional inconsistencies were found.
If the incidence of prevention of lung weight gain by the drug used is compared between the pre-treatment and the post-treatment experiments overall, it is found that 14 out of 49 pre-treatment experiments (29%) indicate prevention of lung weight gain, compared to only 3 out of 32 post-treatment experiments (9%). This suggests that pretreatment may be more effective than post-treatment, at least for some of the drugs examined here. Nevertheless, the finding that post-treatment appeared helpful in three instances suggests that a post-treatment therapy may be developed.
On the basis of presumed mode of action of these drugs it is difficult to formulate a role for any of them in accentua&ig lung weight gain after gas exposure. The finding that in four instances (i.e., 6% of the experiments) an apparently significant weight gain was noted appears more likely due to random difficulties with restraint during exposure, .or aspiration of blood during the necropsy procedure.
In the montality results, the effect of the drugs in reducing the number of deaths during the post-exposure observation periods was examined. The ratio of drug-treated to vehicle-treated deaths was significant, using Fisher's exact test, in only two instances. Ibuprophen and U78517F, used as post-treatment of CG exposure, was followed by significantly fewer deaths in the drug-treated group than in the vehicle-treated group. The ratio was favorable (i.e., more rats died in the vehicle group than in the drug-treated group) in 14 out of 21 experiments examining pre-treatment results (this excludes the hydroxyurea experiments, in which dehydration due to diarrhea may have influenced results). When post-treatment mortality results are compared, the ratio was favorable in only 10 out of 21 experiments.
In the pathology scoring of the lung sections, the effect of the drugs in reducing the severity of lung pathology was examined. The effects were favorable (pathology scores were greater in the vehicle-treated than in the drug-treated groups) in 12 out of 17 pretreatment experiments and in 4 out of 12 post-treatment experiments.
More often than not the mortality ratios and the pathology scores lay in the same direction as the lung weight indices, but in some experiments, either or both trended in a direction opposite to the lung weight ratios. No pattern to these inconsistencies was discerned. The number of animals studied was too small to allow any conclusions as to whether or not any of the drugs had effects on mortality or lung pathology different from their effects on pulmonary weight gain.
The current profusion of theories as to how toxic gases might produce tissue injury (Halliwell et al., 1988) makes it difficult to use the results of these experiments to decide between various possible mechanisms of toxic lung injury. The results are entirely consistent with toxic oxygen species as a partial or major source of the injury. In view of the reduction in lung edema which appears to have resulted from pretreatment with hydroxyurea, leukocytes appear to be involved to a significant extent in the injury produced by TFD, and possibly CG and PFIB. In view of the effectiveness of U78517F, iron chelation, lipid hydroperoxide and superoxide ion scavenging are all possible mechanisms of therapeutic effect. But, in these experiments, each drug was studied in only one dosage, one route of administration, and with two timings of administration. In the absence of a therapeutic or preventive effect, one cannot be sure that another dose, route of administration or dose timing might have shown effectiveness. Thus, absence of therapeutic effect in these experiments cannot be used to rule out the postulated mechanism of that particular drugs action as a source of prevention of the toxic effect of the gas used for producing the edema. 
